FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc. No specific changes are detailed in the excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Neupro (rotigotine)

Snippet

SUPPL AP for NEUPRO (ROTIGOTINE)